SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹32 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr |
Equity - Authorised | ₹43 Cr | ₹43 Cr | ₹38 Cr | ₹33 Cr | ₹33 Cr |
Equity - Issued | ₹32 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr |
Equity Paid Up | ₹32 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | ₹234 Cr | - | - | - |
Total Reserves | ₹480 Cr | ₹-230 Cr | ₹-194 Cr | ₹-45 Cr | ₹270 Cr |
Securities Premium | ₹2,038 Cr | ₹1,106 Cr | ₹940 Cr | ₹940 Cr | ₹940 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹-1,592 Cr | ₹-1,371 Cr | ₹-1,169 Cr | ₹-1,019 Cr | ₹-704 Cr |
General Reserves | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹480 Cr | ₹-230 Cr | ₹-194 Cr | ₹-45 Cr | ₹270 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹513 Cr | ₹31 Cr | ₹-168 Cr | ₹-19 Cr | ₹296 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | ₹113 Cr | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | ₹75 Cr | ₹150 Cr | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | ₹-75 Cr | ₹-38 Cr | - | - |
Unsecured Loans | - | - | - | ₹6.38 Cr | ₹1.09 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | ₹0.55 Cr | ₹0.55 Cr | ₹1.09 Cr |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | ₹-0.55 Cr | ₹5.83 Cr | - |
Deferred Tax Assets / Liabilities | - | - | - | - | - |
Deferred Tax Assets | ₹28 Cr | ₹16 Cr | ₹21 Cr | ₹23 Cr | ₹13 Cr |
Deferred Tax Liability | ₹28 Cr | ₹16 Cr | ₹21 Cr | ₹23 Cr | ₹13 Cr |
Other Long Term Liabilities | ₹130 Cr | ₹69 Cr | ₹43 Cr | ₹39 Cr | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹8.14 Cr | ₹8.15 Cr | ₹8.63 Cr | ₹10 Cr | ₹6.11 Cr |
Total Non-Current Liabilities | ₹138 Cr | ₹77 Cr | ₹165 Cr | ₹56 Cr | ₹7.20 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹148 Cr | ₹72 Cr | ₹91 Cr | ₹159 Cr | ₹83 Cr |
Sundry Creditors | ₹148 Cr | ₹72 Cr | ₹91 Cr | ₹159 Cr | ₹83 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹24 Cr | ₹94 Cr | ₹56 Cr | ₹11 Cr | ₹7.66 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹0.00 Cr | ₹0.03 Cr | ₹0.29 Cr | ₹0.29 Cr | ₹0.31 Cr |
Interest Accrued But Not Due | - | ₹0.57 Cr | ₹1.93 Cr | ₹0.02 Cr | ₹0.03 Cr |
Share Application Money | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.01 Cr |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹24 Cr | ₹93 Cr | ₹54 Cr | ₹11 Cr | ₹7.31 Cr |
Short Term Borrowings | ₹0.05 Cr | - | ₹80 Cr | ₹60 Cr | - |
Secured ST Loans repayable on Demands | ₹0.05 Cr | - | - | - | - |
Working Capital Loans- Sec | ₹0.05 Cr | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | ₹80 Cr | ₹60 Cr | - |
Other Unsecured Loans | ₹-0.05 Cr | - | - | - | - |
Short Term Provisions | ₹6.49 Cr | ₹5.28 Cr | ₹5.75 Cr | ₹5.31 Cr | ₹4.46 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹6.49 Cr | ₹5.28 Cr | ₹5.75 Cr | ₹5.31 Cr | ₹4.46 Cr |
Total Current Liabilities | ₹179 Cr | ₹171 Cr | ₹233 Cr | ₹235 Cr | ₹95 Cr |
Total Liabilities | ₹830 Cr | ₹280 Cr | ₹230 Cr | ₹273 Cr | ₹398 Cr |
ASSETS | |||||
Gross Block | ₹146 Cr | ₹133 Cr | ₹123 Cr | ₹136 Cr | ₹80 Cr |
Less: Accumulated Depreciation | ₹40 Cr | ₹41 Cr | ₹32 Cr | ₹32 Cr | ₹23 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹106 Cr | ₹92 Cr | ₹91 Cr | ₹104 Cr | ₹58 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹1.87 Cr | ₹3.72 Cr | ₹5.23 Cr | ₹3.57 Cr | ₹24 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹65 Cr | ₹68 Cr | ₹71 Cr | ₹69 Cr | ₹59 Cr |
Other Non Current Assets | ₹178 Cr | ₹23 Cr | ₹0.15 Cr | ₹0.20 Cr | ₹0.12 Cr |
Total Non-Current Assets | ₹375 Cr | ₹209 Cr | ₹167 Cr | ₹205 Cr | ₹141 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹291 Cr | ₹12 Cr | ₹6.43 Cr | ₹8.49 Cr | ₹211 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹291 Cr | ₹12 Cr | ₹6.43 Cr | ₹8.49 Cr | ₹211 Cr |
Inventories | - | - | - | - | - |
Raw Materials | - | - | - | - | - |
Work-in Progress | - | - | - | - | - |
Finished Goods | - | - | - | - | - |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | - | - | - | - | - |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹33 Cr | ₹28 Cr | ₹18 Cr | ₹16 Cr | ₹10 Cr |
Debtors more than Six months | - | - | ₹0.18 Cr | - | - |
Debtors Others | ₹33 Cr | ₹28 Cr | ₹17 Cr | ₹16 Cr | ₹10 Cr |
Cash and Bank | ₹112 Cr | ₹1.23 Cr | ₹9.31 Cr | ₹0.46 Cr | ₹0.68 Cr |
Cash in hand | ₹0.00 Cr | ₹0.00 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.00 Cr |
Balances at Bank | ₹112 Cr | ₹1.22 Cr | ₹9.31 Cr | ₹0.45 Cr | ₹0.67 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹3.98 Cr | ₹2.50 Cr | ₹4.79 Cr | ₹2.86 Cr | ₹2.57 Cr |
Interest accrued on Investments | ₹0.63 Cr | - | - | ₹0.00 Cr | ₹0.01 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹3.33 Cr | ₹2.48 Cr | ₹4.79 Cr | ₹2.86 Cr | ₹2.56 Cr |
Other current_assets | ₹0.02 Cr | ₹0.03 Cr | - | - | - |
Short Term Loans and Advances | ₹16 Cr | ₹28 Cr | ₹22 Cr | ₹39 Cr | ₹33 Cr |
Advances recoverable in cash or in kind | ₹4.58 Cr | ₹3.91 Cr | ₹0.80 Cr | ₹2.48 Cr | ₹4.94 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹11 Cr | ₹24 Cr | ₹21 Cr | ₹37 Cr | ₹28 Cr |
Total Current Assets | ₹455 Cr | ₹71 Cr | ₹60 Cr | ₹67 Cr | ₹257 Cr |
Net Current Assets (Including Current Investments) | ₹276 Cr | ₹-100 Cr | ₹-174 Cr | ₹-168 Cr | ₹162 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹830 Cr | ₹280 Cr | ₹230 Cr | ₹273 Cr | ₹398 Cr |
Contingent Liabilities | ₹84 Cr | ₹84 Cr | ₹94 Cr | ₹186 Cr | ₹175 Cr |
Total Debt | ₹0.05 Cr | ₹75 Cr | ₹231 Cr | ₹67 Cr | ₹1.64 Cr |
Book Value | 15.80 | -7.47 | -6.42 | -0.71 | 11.30 |
Adjusted Book Value | 15.80 | -7.47 | -6.42 | -0.71 | 11.30 |
Compare Balance Sheet of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹8,819.9 Cr | -18.5% | -25.3% | 47.2% | Stock Analytics | |
SYNGENE INTERNATIONAL | ₹28,098.8 Cr | -2% | 1.9% | 12.6% | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹10,283.9 Cr | -1.5% | 7.3% | 42.9% | Stock Analytics | |
JUST DIAL | ₹9,148.2 Cr | 0.9% | 33.5% | 60.5% | Stock Analytics | |
DREAMFOLKS SERVICES | ₹2,775.6 Cr | 2.2% | 9.4% | 21% | Stock Analytics | |
EKI ENERGY SERVICES | ₹960.4 Cr | 5.9% | 9.6% | -18.4% | Stock Analytics |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | -18.5% |
-25.3% |
47.2% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses